Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1283718-57-9

Post Buying Request

1283718-57-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1283718-57-9 Usage

Description

Methyl 2-fluoro-4-(hydroxymethyl)benzoate is a chemical compound with the molecular formula C9H9FO3. It is an ester, consisting of a methyl group, a fluoro substituent, and a hydroxymethyl group attached to a benzene ring.

Uses

Used in Pharmaceutical Industry:
Methyl 2-fluoro-4-(hydroxymethyl)benzoate is used as an intermediate in the synthesis of various drugs and active pharmaceutical ingredients for its potential in creating complex molecules.
Used in Organic Chemistry:
Methyl 2-fluoro-4-(hydroxymethyl)benzoate is used as a building block in the creation of complex molecules for its potential in organic chemistry.
Used in Pesticide Industry:
Methyl 2-fluoro-4-(hydroxymethyl)benzoate may be used as a pesticide due to its aromatic nature.
Used in Flavoring Industry:
Methyl 2-fluoro-4-(hydroxymethyl)benzoate may have potential applications as a flavoring agent due to its aromatic nature.

Check Digit Verification of cas no

The CAS Registry Mumber 1283718-57-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,3,7,1 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1283718-57:
(9*1)+(8*2)+(7*8)+(6*3)+(5*7)+(4*1)+(3*8)+(2*5)+(1*7)=179
179 % 10 = 9
So 1283718-57-9 is a valid CAS Registry Number.

1283718-57-9Relevant articles and documents

NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST

-

Paragraph 0515, (2018/10/04)

The present invention relates to a novel imidazole compound or a pharmaceutically acceptable salt thereof having a melanocortin receptor agonistic activity, and medical use thereof. The present invention relates to an imidazole compound represented by general formula [I] [wherein: Ring A represents an optionally substituted aryl group or the like; R1 represents a hydrogen atom, an optionally substituted alkyl group, or the like; R2 represents a hydrogen atom, a halogen atom, or the like; and R3 represents an optionally substituted alkyl group] or a pharmaceutically acceptable salt thereof.

Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease

Rabal, Obdulia,Sánchez-Arias, Juan A.,Cuadrado-Tejedor, Mar,de Miguel, Irene,Pérez-González, Marta,García-Barroso, Carolina,Ugarte, Ana,Estella-Hermoso de Mendoza, Ander,Sáez, Elena,Espelosin, Maria,Ursua, Susana,Haizhong, Tan,Wei, Wu,Musheng, Xu,Garcia-Osta, Ana,Oyarzabal, Julen

, p. 506 - 524 (2018/03/21)

We have identified chemical probes that act as dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors (>1 log unit difference versus class I HDACs) to decipher the contribution of HDAC isoforms to the positive impact of dua

NOVEL COMPOUNDS

-

Paragraph 0553, (2015/03/04)

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, X, m, R2, Y, R3, Z, n, R4, A and B are as defined in the specification, processes for their prep

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1283718-57-9